You are here:
ALL-REZ BFM- and the new IntReALL study
Trials on the treatment of children with relapses of acute lymphatic leukemia are done to achieve a constant improvement of diagnosis, therapy, and prognosis for affected children.
In the Department for Pediatric Hematology and Oncology of the Charité theses studies are conducted by the team of PD Dr. Stackelberg.
ALL - Acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL), also known as acute lymphatic leukemia, is a malignant disease of the bone marrow. It originates in the bone marrow, the place in the human body, where white blood cells (leukocytes) are formed. An overproduction of impaired white blood cells results in ALL. For more information about this disease, please visit the website of the information portal of the Society for Peadiatric Haematology/Oncology.